Basel – Earlybirds Invest https://earlybirdsinvest.com Latest Crypto News Sun, 18 May 2025 22:35:06 +0000 en-US hourly 1 https://wordpress.org/?v=6.9.11 https://i0.wp.com/earlybirdsinvest.com/wp-content/uploads/2024/12/cropped-New-Project-2024-12-17T235703.455.png?fit=32%2C32&ssl=1 Basel – Earlybirds Invest https://earlybirdsinvest.com 32 32 240146708 Billion Bitcoin Trading: Basel Medical’s Unconventional Financial Strategy https://earlybirdsinvest.com/billion-bitcoin-trading-basel-medicals-unconventional-financial-strategy/ https://earlybirdsinvest.com/billion-bitcoin-trading-basel-medicals-unconventional-financial-strategy/#respond Sun, 18 May 2025 22:35:06 +0000 https://earlybirdsinvest.com/billion-bitcoin-trading-basel-medicals-unconventional-financial-strategy/ Basel Medical Group, a Singapore-based healthcare company, is taking an unexpected turn. Instead of expanding clinics or launching new medical services, they are preparing to add a massive $1 billion in Bitcoin to the Corporate Treasury Department. Basel’s investment in Bitcoin healthcare is turning his head, especially since most of these moves come from high tech and finance. The move has swept through the market and sent a slip of the company’s stock price, but management says it is part of a long-term plan to strengthen its business in a changing financial environment.

Healthcare meets encryption

At first glance, medical companies jumping into Bitcoin may raise eyebrows. However, Basel Medical says the decision is not about hype or headlines. According to CEO Dr. Darren Chhoa, this is part of a financial pivot designed to support the company’s growth across Asia, providing greater flexibility with how it manages its reserves.

Rather than buying Bitcoin entirely in cash, the company uses the stock swap model. This means that Newnet individuals and institutions will receive Basel shares in exchange for donating bitcoin to the company’s balance sheet. In other words, Basel has won BTC, investors are fair, and the company’s cash remains untouched for now.

Discover: Best New Cryptocurrencies to Invest in 2025

The market didn’t love it

Investors did not respond with applause. Basel’s stocks fell by about 15% after the announcement. Such a reaction is not uncommon when traditional companies try to code. Bitcoin has a track record of big highs and sudden drops, and shareholders tend to worry about what will happen if the value is tanked.

–
price
Market capitalization
–
–
–





Still, this is not a random crypto gamble. The company has made it clear that they have not shifted their focus from healthcare. This move is intended to sit with existing plans and does not replace them. It’s a play of diversification, not a real brand.

Not the first, but definitely the first in healthcare

Basel will join a club from a small but growing public company that has chosen to hold Bitcoin as part of its financial strategy. Most of the names on that list are from technology or finance. MicroStrategy is the most well-known example, transforming Bitcoin Holdings into a critical part of its identity. Tesla has been pulled back ever since, but it has made waves with its own investment.

It is the sector that makes Basel different. I haven’t seen many healthcare companies immerse themselves in code. This makes this move a bit of an outlier, perhaps indicating that financial strategies are beginning to change in the surprising corners of the business world.

Discovered: Top 20 Cryptography to Buy in May 2025

What is Endgame?

Basel said the deal will close at some point in the quarter, assuming everything will be cleared by regulators. The company has not revealed who the investors are yet or how Bitcoin will be managed once it is featured in the book. These details can shape how this works, especially when prices fluctuate dramatically in either direction.

For now, the focus is on how Basel balances responsibility. Bitcoin is unstable, but Basel thinks it can be used as a long-term asset, but it sticks to its central mission. With this $1 billion Bitcoin Healthcare investment, Basel Medical is making a big bet on Bitcoin while continuing to commit to its healthcare mission.

Whether it turns out to be stunning or short-lived, one thing be: It was a bold move that attracted everyone’s attention.

Discover: 20+ Next Cryptocurrency to Explode in 2025

For the latest market updates, please join us in the discrepancy in 99bitcoins news here

Key takeout

  • Singapore-based Basel Medical is adding $1 billion in Bitcoin to the Treasury through its stock swap model rather than direct cash purchases.

  • The move allows investors to trade Bitcoin with Basel stocks, providing company BTC exposure without touching on cash reserves.

  • After the announcement, Basel’s shares fell 15%, reflecting market concerns regarding traditional healthcare companies’ volatility and crypto risk.

  • This is a rare entry into crypto by healthcare companies, placing Basel in a small group of non-technology companies using Bitcoin as a financial asset.

  • Basel argues that Bitcoin trading will not change the focus of healthcare, describing the move as a diversification rather than a change in business models.


    • Billion Billion Bitcoin Trading: Basel Medical’s unconventional financial strategy first appeared in 99 Bitcoin.

    ]]>     https://earlybirdsinvest.com/billion-bitcoin-trading-basel-medicals-unconventional-financial-strategy/feed/ 0 36993     Basel Medical Group to add $1B in Bitcoin to treasury amid falling share prices https://earlybirdsinvest.com/basel-medical-group-to-add-1b-in-bitcoin-to-treasury-amid-falling-share-prices/ https://earlybirdsinvest.com/basel-medical-group-to-add-1b-in-bitcoin-to-treasury-amid-falling-share-prices/#respond Sat, 17 May 2025 10:09:38 +0000 https://earlybirdsinvest.com/basel-medical-group-to-add-1b-in-bitcoin-to-treasury-amid-falling-share-prices/

    Singapore-based Basel Medical Group (BMGL) announced plans to acquire $1 billion worth of Bitcoin (BTC) to strengthen its balance sheet and accelerate expansion across Asian markets.

    Basel also revealed that the proposed transaction is being negotiated with a consortium of institutional investors and high-net-worth individuals active in the crypto sector. 

    Basel CEO Darren Chhoa said the $1 billion acquisition would give the firm “unprecedented capacity” to execute its Asia growth strategy.

    He added that capital infusion would create one of the strongest balance sheets among Asia-focused medical providers, enabling it to pursue mergers and acquisitions and enhance its financial resilience.

    The firm described the initiative as a “landmark transaction” that would represent one of the largest Bitcoin allocations by a healthcare group in the Asia-Pacific region.

    The announcement highlighted an intention to finalize the deal within the current quarter, subject to regulatory approval and standard closing conditions. 

    Transaction structure and strategic objectives

    The proposed acquisition will occur through a share-swap arrangement with external investors, rather than a direct cash purchase of Bitcoin from reserves. Basel stated that this model offers enhanced capital efficiency while preserving liquidity for healthcare operations.

    The company’s management sees the diversification into Bitcoin as a hedge against currency volatility and inflation risks in emerging markets, particularly in regions where it seeks to expand. 

    BMGL also sees the acquisition as a mechanism to attract strategic partnerships in the healthcare and digital asset sectors.

    Basel’s leadership said it would provide additional details upon the transaction’s completion and remain committed to regulatory compliance in all jurisdictions where it operates.

    Market reaction diverges from Bitcoin trend

    Despite Basel’s framing of the move as a financial strengthening initiative, the company’s stock price declined sharply following the announcement.

    Its shares fell to a low of $2.10 despite climbing 68% earlier in the day to a high of $3.41 from the daily opening price of $2.84. The volatility adds to the massive 57% drawdown observed on May 14.

    Despite the tumultuous price action for the day, the share price mounted a recovery before the trading day ended to close the day down 9.89% to $2.37 as of press time.

    The reaction contrasts with recent market behavior in other firms announcing Bitcoin strategies. 

    On March 12, Rumble saw its stock price rise 5% after announcing a Bitcoin acquisition. Japanese firm Metaplanet gained nearly 20% in a single session on July 22 after disclosing a purchase of more than 20 BTC. 

    HK Asia Holdings surged 92.98% on Feb. 13 after acquiring 1 BTC for approximately $96,150. Meanwhile, Brazilian fintech Méliuz gained 16.3% on March 6 after detailing its Bitcoin investment framework,

    While Basel’s initial market response diverged from those precedents, the company maintains that the transaction is part of a broader financial restructuring initiative rather than a speculative bet.

    Mentioned in this article
    Latest Alpha Market Report
    ]]>     https://earlybirdsinvest.com/basel-medical-group-to-add-1b-in-bitcoin-to-treasury-amid-falling-share-prices/feed/ 0 36719